Inventia Healthcare Limited has initiated a voluntary recall of 11,460 bottles of Chlorthalidone 25mg tablets, a medication commonly prescribed for high blood pressure and fluid retention. According to a U.S. Food and Drug Administration (FDA) enforcement report, the recall was prompted by the medication’s failure to meet dissolution specifications.
Dissolution testing is a critical quality control measure that ensures a medication dissolves correctly and releases the intended dosage into the body. The FDA noted that the affected tablets may be ineffective or deliver an incorrect dose, posing potential health risks to patients relying on the drug for blood pressure management.
The affected products include 100-count and 1,000-count bottles with batch numbers RISA24001 and RISB24002, respectively. Both batches have an expiration date of April 2027. The medication was distributed in the United States by Rising Pharma Holdings, Inc.
Health officials advise patients to check their medication bottles for these specific batch numbers. Patients currently taking Chlorthalidone are strongly cautioned against stopping their medication abruptly without consulting a doctor or healthcare provider. Pharmacists can assist in verifying if a specific prescription is part of the recalled stock and provide guidance on next steps for replacement or safe disposal.